US Theranostics Market Surges 40%; Is Precision Cancer Care Entering Its Breakthrough Era?
The US theranostics market is no longer a niche innovation; it is becoming a clinical necessity. In 2024, North America […]
The US theranostics market is no longer a niche innovation; it is becoming a clinical necessity. In 2024, North America […]